A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s ...

An interview with Dr. Lisa Carey from the University of North Carolina Lineberger Comprehensive Cancer Center in Chapel Hill, NC, panel member on “Use of Immune Checkpoint Inhibitor Pembrolizumab in ...

During a live event, Bruna Pellini, MD, discussed IO monotherapy as a first-line option for non–small cell lung cancer with ...

Immune checkpoint inhibitors have changed the future of cancer care. These powerful treatments use the body’s own immune ...

Two studies on checkpoint inhibitors in multiple myeloma presented at the ASH meeting evaluated pembrolizumab in combination with an IMiD. In the multicenter phase 1 KEYNOTE-023 study ...

A fatal case of immune checkpoint inhibitor-mediated myasthenia gravis, myositis, and cardiomyopathy overlap syndrome in urothelial carcinoma. Cancer Rep . 2024;7(7):e2140. doi:10.1002/cnr2.2140 ...

The checkpoint inhibitor pembrolizumab (Keytruda) offers patients with advanced head and neck cancers longer survival time, according to a new global study led by Yale Cancer Center (YCC).

The optimal second-line treatment for patients with advanced hepatocellular carcinoma (HCC) previously treated with immune checkpoint inhibitors has not been established.

Immune checkpoint inhibitors have an established role in the treatment of newly diagnosed metastatic kidney cancer. ... The KEYNOTE-427 study enrolled patients with newly diagnosed mRCC; in that study ...

Emerging evidence indicates JAK inhibitors could be a valuable alternative for managing checkpoint inhibitor–induced immune toxicities, especially in difficult-to-treat cases.

Checkpoint inhibitors are really incredible drugs, ... I would be frightened to put a patient with really active GCA on pembrolizumab or say that it’s safe without their disease being controlled.

Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-Risk, Early-Stage TNBC: ASCO Guideline Rapid Recommendation Update — An ASCO Reading Room selection by MedPage Today ...